Cognoptix

Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.

Cognoptix, Inc. (formerly Neuroptix) is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix, Inc.'s goal is to provide clinicians with a quick, predictive, reliable, inexpensive and widely available test, enabling early diagnosis and treatment. The company maintains an active interest in collaboration with major pharmaceutical companies to facilitate testing of new Alzheimer's drugs, and with academic institutions to promote research in this area.